ClassID:

94044

C07D205/08 - CPC Classification

Classification description:

Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Sub-classes:
Recent Application in this class:
#1
20260139272
2026-05-21

LACTAM-MODIFIED ADENO-ASSOCIATED VIRUS VECTORS

#2
20260125335
2026-05-07

SYNTHETIC CANNABINOID ANALOGS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF TREATING BACTERIAL INFECTIONS AND OTHER DISORDERS

#3
20250340512
2025-11-06

COMPOUNDS FOR THE REDUCING LIPOTOXIC DAMAGE

#4
20250234703
2025-07-17

Organic Compound And Organic Light-Emitting Element Comprising Same

#5
20250214931
2025-07-03

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

#6
20240343688
2024-10-17

COMPOUNDS FOR THE REDUCING LIPOTOXIC DAMAGE

#7
20240294475
2024-09-05

Antagonists of human integrin α4β7

#8
20240246908
2024-07-25

TEAD INHIBITORS

#9
20240059733
2024-02-22

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

#10
20230295082
2023-09-21

MODIFIED EZETIMIBE DRUG FOR CANCER TREATMENT

#11
20230250057
2023-08-10

Compounds for the reducing lipotoxic damage

#12
20230148598
2023-05-18

BETA-LACTAMS AND THEIR USE AS HERBICIDES

#13
20230037322
2023-02-09

Cytotoxic actin-targeting compounds

#14
20220380803
2022-12-01

LACTAM-MODIFIED ADENO-ASSOCIATED VIRUS VECTORS

#15
20220340529
2022-10-27

ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)

#16
20220324797
2022-10-13

Compounds for the reducing lipotoxic damage

#17
20220304958
2022-09-29

SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX

#18
20220281813
2022-09-08

Therapeutic compounds and compositions

#19
20220251039
2022-08-11

Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof

#20
20220204447
2022-06-30

Chiral-substituted poly-N-vinylpyrrolidinones and complexes with bimetallic nanoclusters and uses thereof in asymmetric oxidation reactions

#21
20220002242
2022-01-06

Spiro-lactam NMDA receptor modulators and uses thereof

#22
20210139421
2021-05-13

Compounds for the reducing lipotoxic damage

#23
20210024575
2021-01-28

Therapeutically active compounds and their methods of use

#24
20200392150
2020-12-17

Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof

#25
20200385352
2020-12-10

Antagonists of human integrin (α4)(β7)

#26
20200306233
2020-10-01

Cytotoxic actin-targeting compounds

#27
20200182617
2020-06-11

Necrosis inhibitors

#28
20200164353
2020-05-28

Compositions and methods for selective carbonylation of heterocyclic compounds

#29
20200024226
2020-01-23

Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same

#30
20190359567
2019-11-28

Therapeutic compounds and compositions

#31
20190315802
2019-10-17

Therapeutically active compounds and their methods of use

#32
20190315692
2019-10-17

Antagonists of human integrin α4β7

#33
20190315680
2019-10-17

Inhibitors of creatine transport and uses thereof

#34
20190256479
2019-08-22

Method of preparing ezetimibe and intermediate thereof

#35
20190161442
2019-05-30

Spiro-lactam NMDA receptor modulators and uses thereof

#36
20190127323
2019-05-02

Beta lactams as modulators of glutamate uptake and methods for use thereof

#37
20190119293
2019-04-25

Synthesis of lactams

#38
20190038578
2019-02-07

Necrosis inhibitors

#39
20180244614
2018-08-30

Therapeutic compounds and compositions

#40
20180194802
2018-07-12

Therapeutically active compositions and their methods of use

#41
20180127368
2018-05-10

Tricyclic sulfones as ROR gamma modulators

#42
20180099930
2018-04-12

Method for preparing azetidinone compound and intermediate of azetidinone compound

#43
20170355671
2017-12-14

Peripherally substituted monocyclic beta-lactams

#44
20170304237
2017-10-26

Necrosis inhibitors

#45
20170247510
2017-08-31

Poly-β-peptides from functionalized β-lactam monomers and antibacterial compositions containing same

#46
20170121281
2017-05-04

Method for preparing azetidinone compound and intermediate of azetidinone compound

#47
20170114016
2017-04-27

Crystal forms of azetidinone compounds and preparing methods thereof

#48
20170114015
2017-04-27

Crystal forms of azetidinone compounds and preparing methods thereof

#49
20170114014
2017-04-27

B-LACTAM COMPOUNDS

#50
20170050924
2017-02-23

Inhibitors of creatine transport and uses thereof

#51
20170037003
2017-02-09

Therapeutic compounds and compositions

#52
20170015703
2017-01-19

Therapeutically active compositions and their methods of use

#53
20160362369
2016-12-15

METHOD FOR PRODUCING OPTICALLY ACTIVE AZETIDINONE COMPOUND

#54
20160289781
2016-10-06

Strain of marine oil-degrading bacteria, compounds obtained by fermentation and their applications

#55
20160280642
2016-09-29

Enzymatic process for the preparation of (S)-5-(4-fluoro-phenyl)-5-hydroxy-1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe

#56
20160229841
2016-08-11

Beta lactams as modulators of glutamate uptake and methods for use thereof

#57
20160194307
2016-07-07

Compounds useful as immunomodulators

#58
20150327547
2015-11-19

N-alkylthio beta-lactams, alkyl-coenzyme A asymmetric disulfides, and aryl-alkyl disulfides as anti-bacterial agents

#59
20150322205
2015-11-12

Poly-beta-peptides from functionalized beta-lactam monomers and antibacterial compositions containing same

#60
20150218091
2015-08-06

Crystal forms of azetidinone compounds and preparing methods thereof

#61
20150166479
2015-06-18

Process for synthesis of ezetimibe and intermediates used in said process

#62
20150148533
2015-05-28

Synthetic route for the preparation of β-aminobutyryl substituted 5,6,7,8-tetrahydro[1,4]diazolo[4,3-alpha ]pyrazin-7-yl compounds

#63
20150087831
2015-03-26

Synthesis of lactams

#64
20150080578
2015-03-19

Taxane compounds, compositions and methods

#65
20150031108
2015-01-29

Processes for preparing peptide conjugates and linkers

#66
20150018565
2015-01-15

METHOD OF PREPARING EZETIMIBE

#67
20140249186
2014-09-04

Taxane compounds, compositions and methods

#68
20140235565
2014-08-21

-alkylthio beta-lactams, alkyl-coenzyme A asymmetric disulfides, and aryl-alkyl disulfides as anti-bacterial agents

#69
20140200205
2014-07-17

Thio derivatives bearing lactams as potent HDAC inhibitors and their uses as medicaments

#70
20140155371
2014-06-05

MULTICOMPONENT CRYSTALLINE SYSTEM OF EZETIMIBE AND PROLINE

#71
20140093518
2014-04-03

Chemically Programmed Vaccination

#72
20140038106
2014-02-06

N-acyl-β-lactam derivative, macromolecular compound, and photoresist composition

#73
20130324687
2013-12-05

Compounds, monomers, and polymers containing a carbonate linkage

#74
20130270873
2013-10-17

Securing element, particularly suitable for use with tablet-arm chairs

#75
20130252935
2013-09-26

Monobactams

#76
20130225594
2013-08-29

Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions

#77
20130190487
2013-07-25

PROCESS FOR THE PREPARATION OF EZETIMIBE AND DERIVATIVES THEREOF

#78
20130190249
2013-07-25

Therapeutically active compositions and their methods of use

#79
20130040930
2013-02-14

Amide derivative and use thereof as medicine

#80
20120322761
2012-12-20

Heterocyclic CETP inhibitors

#81
20120309734
2012-12-06

COMBRETASTATIN DERIVATIVES AND USES THEREFOR

#82
20120302542
2012-11-29

MONOBACTAMS

#83
20120220634
2012-08-30

Taxane compounds, compositions and methods

#84
20120214785
2012-08-23

Compounds, pharmaceutical compositions and uses thereof

#85
20120208994
2012-08-16

Azetidinone compounds and medical use thereof

#86
20120184731
2012-07-19

Method for synthesizing beta lactam compounds by decomposition of an alpha-diazo-beta-ketoamide using a fluorescent light source

#87
20120148954
2012-06-14

N-acyl-β-lactam derivative, macromolecular compound, and photoresist composition

#88
20120083601
2012-04-05

Process for the synthesis of azetidinones

#89
20120029185
2012-02-02

Intermediates in the preparation of 1,4-diphenyl azetidinone

#90
20120028316
2012-02-02

Enzymatic process for the preparation of (S)-5-(4-fluoro-phenyl)-5-hydroxy-1morpholin-4-yl-pentan-1-one, an intermediate of Ezetimibe and further conversion to Ezetimibe

#91
20120022248
2012-01-26

β-lactam compounds

#92
20120004429
2012-01-05

Taxane compounds, compositions and methods

#93
20110311516
2011-12-22

Chemically programmed vaccination

#94
20110196127
2011-08-11

Poly-β-peptides from functionalized β-lactam monomers and antibacterial compositions containing same

#95
20110183956
2011-07-28

PROCESS FOR THE SYNTHESIS OF EZETIMIBE AND INTERMEDIATES USEFUL THEREFOR

#96
20110144327
2011-06-16

PROCESS FOR THE SYNTHESIS OF AZETIDINONES

#97
20110130378
2011-06-02

EZETIMIBE PROCESS AND COMPOSITION

#98
20110065912
2011-03-17

NEW METHODS FOR THE PREPARATION OF TAXANES USING CHIRAL AUXILIARIES

#99
20110054191
2011-03-03

NEW METHODS FOR THE PREPARATION OF TAXANES USING CHIRAL AUXILIARIES

#100
20110046389
2011-02-24

INTERMEDIATES FOR THE PREPARATION OF (3R, 4S)-1-(4-FLUOROPHENYL)-3-[(3S)-3-(4-FLUOROPHENYL)-3-HYDROXYPROPYL)]-4-(4-HYDROXYPHENYL)-2-AZETIDINONE

#101
20110009617
2011-01-13

Ruthenium Catalysts and Uses Thereof

#102
20100297077
2010-11-25

Aryl potassium channel blockers and uses thereof

#103
20100267669
2010-10-21

Heterocyclic CETP inhibitors

#104
20100222250
2010-09-02

Poly-beta-peptides from functionalized beta-lactam monomers and antibacterial compositions containing same

#105
20100216761
2010-08-26

NOVEL AZETIDINONES USEFUL AS INHIBITORS OF ELASTASE

#106
20100216759
2010-08-26

2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia

#107
20100168414
2010-07-01

PROCESSES FOR PREPARING EZETIMIBE AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION THEREOF

#108
20100168075
2010-07-01

Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions

#109
20100160282
2010-06-24

NOVEL DIPHENYLAZETIDINONES, PROCESS FOR THEIR PREPARATION, MEDICAMENTS COMPRISING THESE COMPOUNDS AND THEIR USE

#110
20100152156
2010-06-17

2-Azetidinone Derivatives For The Treatment Of Hyperlipidaemic Diseases

#111
20100151035
2010-06-17

PHARMACEUTICAL COMPOSITIONS OF POORLY SOLUBLE DRUGS

#112
20100144698
2010-06-10

SUBSTITUTED AZETIDINONES

#113
20100137273
2010-06-03

2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions

#114
20100099657
2010-04-22

Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity

#115
20100075943
2010-03-25

1-adamantyl azetidin-2-one derivatives and drugs containing same

#116
20100035857
2010-02-11

ANTI-HYPERCHOLESTEROLEMIC COMPOUNDS

#117
20100010212
2010-01-14

Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe

#118
20100004184
2010-01-07

Anti-hypercholesterolemic compounds

#119
20090318404
2009-12-24

Substituted beta-lactams

#120
20090275524
2009-11-05

NOVEL HYPOCHOLESTEROLEMIC COMPOUNDS

#121
20090264402
2009-10-22

NOVEL DIPHENYLAZETIDINONE SUBSTITUTED BY PIPERAZINE-1-SULFONIC ACID AND HAVING IMPROVED PHARMACOLOGICAL PROPERTIES

#122
20090247743
2009-10-01

PREPARATION OF BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN

#123
20090227786
2009-09-10

PROCESSES FOR PREPARING INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF EZETIMIBE

#124
20090216009
2009-08-27

Process for the production of ezetimibe and intermediates used in this process

#125
20090215740
2009-08-27

Therapeutic substituted beta-lactams

#126
20090203578
2009-08-13

Certain crystalline diphenylazetidinone hydrates, pharmaceutical compositions thereof and methods for their use

#127
20090186866
2009-07-23

Therapeutic beta-lactams

#128
20090186834
2009-07-23

DIPHENYLHETEROCYCLE CHOLESTEROL ABSORPTION INHIBITORS

#129
20090143351
2009-06-04

SUBSTITUTED AZETIDINONES

#130
20090137796
2009-05-28

Methods for the preparation of taxanes using chiral auxiliaries

#131
20090137546
2009-05-28

Anti-Hypercholesterolemic Compounds

#132
20090131395
2009-05-21

BIPHENYLAZETIDINONE CHOLESTEROL ABSORPTION INHIBITORS

#133
20090099355
2009-04-16

Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids

#134
20090088566
2009-04-02

Usage of poly-3-hydroxybutyrates in preparation of β-lactam compounds

#135
20090069285
2009-03-12

Diphenylazetidinone derivatives possessing cholesterol absorption inhibitor activity

#136
20090062527
2009-03-05

Process for preparing optically active alcohols

#137
20090048441
2009-02-19

Process for the preparation of ezetimibe

#138
20090023708
2009-01-22

Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses

#139
20080318920
2008-12-25

DEUTERIUM-ENRICHED EZETIMIBE

#140
20080287663
2008-11-20

Process For Production Of 4-Biphenylyazetidin-2-Ones

#141
20080281092
2008-11-13

Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use

#142
20080280836
2008-11-13

Anti-hypercholesterolemic biaryl azetidinone compounds

#143
20080274947
2008-11-06

Hydroxy-Substituted Diphenylazetidinones for the Treatment of Hyperlipidemia

#144
20080227974
2008-09-18

Novel Substituted Azetidinones

#145
20080207585
2008-08-28

Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof

#146
20080200669
2008-08-21

Processes For Production of Phenolic 4-Biphenylylazetidin-2-Ones

#147
20080194494
2008-08-14

4-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for Hypercholesterolemia

#148
20080182815
2008-07-31

Asymmetric disulfides and aryl-alkyl disulfides as anti-bacterial agents

#149
20080167255
2008-07-10

4-BIARYLYL-1-PHENYLAZETIDIN-2-ONES

#150
20080154034
2008-06-26

4-alkenyl-2-azetidinone derivatives, process for preparing 4-alkenyl-2-azetidinone derivatives and multicyclic compounds prepared using 4-alkenyl-2-azetidinone derivatives

#151
20080113943
2008-05-15

Therapeutic β-lactams

#152
20080064676
2008-03-13

Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity

#153
20080058305
2008-03-06

Processes for the purification of (3R,4S)-4-(4-hydroxy-protected-phenyl)-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one

#154
20070275909
2007-11-29

Hypocholesterolemic compounds

#155
20070259845
2007-11-08

Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe

#156
20070208179
2007-09-06

Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use

#157
20070197516
2007-08-23

Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity

#158
20070197498
2007-08-23

Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use

#159
20070161577
2007-07-12

Tethered dimers and trimers of 1,4-diphenylazetidin-2-ones

#160
20070155675
2007-07-05

Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof

#161
20070155674
2007-07-05

Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof

#162
20070149776
2007-06-28

Method for producing 1,4-diphenyl azetidinone derivatives

#163
20070149501
2007-06-28

Process for the preparation of diphenyl azetidinone derivatives

#164
20070142304
2007-06-21

Diphenylazetidinone derivatives possessing chloesterol absorption inhibitory activity

#165
20070135631
2007-06-14

Heterocyclic CETP inhibitors

#166
20070135357
2007-06-14

Anti-hypercholesterolemic compounds

#167
20070129540
2007-06-07

Process for the preparation of chiral azetidinones

#168
20070123506
2007-05-31

Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use

#169
20070105832
2007-05-10

Substituted azetidinones

#170
20070099826
2007-05-03

Treatment of diseases associated with the egr-1 enhancer element

#171
20070087404
2007-04-19

Poly-β-peptides from functionalized β-lactam monomers and antibacterial compositions containing same

#172
20070078098
2007-04-05

Anti-hypercholesterolemic compounds

#173
20070072812
2007-03-29

Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones

#174
20070049748
2007-03-01

PREPARATION OF EZETIMIBE

#175
20070049594
2007-03-01

Novel compounds and compositions as cathepsin inhibitors

#176
20070043017
2007-02-22

Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use

#177
20070037971
2007-02-15

PROCESS FOR DESILYLATION OF CARBAPENEM INTERMEDIATES

#178
20070037787
2007-02-15

Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use

#179
20070037785
2007-02-15

Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases

#180
20070032646
2007-02-08

Novel taxanes and methods related to use and preparation thereof

#181
20060281918
2006-12-14

Resolution of enantiomeric mixtures of beta-lactams

#182
20060281914
2006-12-14

β-lactam synthesis

#183
20060270613
2006-11-30

Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use

#184
20060264673
2006-11-23

Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds

#185
20060252929
2006-11-09

Intermediate for carbapenem compound for oral administration and process for producing the same

#186
20060252742
2006-11-09

Therapeutic substituted β-lactams

#187
20060234996
2006-10-19

Novel crystalline form of ezetimibe and processes for the preparation thereof

#188
20060160787
2006-07-20

Methods for preventing and treating cancer using -thiolated β-lactam compounds and analogs thereof

#189
20060160785
2006-07-20

Ezetimibe polymorphs

#190
20060135755
2006-06-22

Process for the synthesis of azetidinones

#191
20060089357
2006-04-27

Novel compounds and compositions as cathepsin inhibitors

#192
20060069137
2006-03-30

Process for ezetimibe intermediate

#193
20060025474
2006-02-02

Bisphenyl compounds useful as vitamin D3 receptor agonists

#194
20060002851
2006-01-05

Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide

#195
20050267049
2005-12-01

Anti-hypercholesterolemic compounds

#196
20050267038
2005-12-01

Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use

#197
20050261504
2005-11-24

Process for preparing N-hydroxyformamido-propyl pyrrolidin compounds and intermediates

#198
20050239766
2005-10-27

Diphenylazetidinone derivatives for treating disorders of the lipid metabolism

#199
20050215794
2005-09-29

Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds

#200
20050209165
2005-09-22

4-Biarylyl-1-phenylazetidin-2-ones

#201
20050171082
2005-08-04

Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same

#202
20050171080
2005-08-04

Polymorphs of ezetimibe and process for preparation thereof

#203
20050107605
2005-05-19

β-Lactams, methods for the preparation of taxanes, and sidechain-bearing taxanes

#204
20050070519
2005-03-31

Cyclisation process for the preparation of c-2 beta-lactam compounds

#205
20050043392
2005-02-24

Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity

#206
20050020563
2005-01-27

Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use